New Key Statistics Module, Z-Score and F-Score
NAS:COLL Key Ratios
Market Cap $ M | 1,254.09 |
Enterprise Value $ M | 1,536.43 |
P/E(ttm) | 15.03 |
PE Ratio without NRI | 6.52 |
Forward PE Ratio | 5.77 |
Price/Book | 5.81 |
Price/Sales | 2.94 |
Price/Free Cash Flow | 6.22 |
Price/Owner Earnings | 9.78 |
Payout Ratio % | -- |
Revenue (TTM) $ M | 576.00 |
EPS (TTM) $ | 2.59 |
Beneish M-Score | -3.25 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | 22.50 |
EV-to-EBIT | 7.17 |
EV-to-EBITDA | 4.30 |
PEG | -- |
Shares Outstanding M | 32.21 |
Net Margin (%) | 17.32 |
Operating Margin % | 35.32 |
Pre-tax Margin (%) | 24.49 |
Quick Ratio | 1.04 |
Current Ratio | 1.11 |
ROA % (ttm) | 8.76 |
ROE % (ttm) | 49.26 |
ROIC % (ttm) | 18.11 |
Dividend Yield % | -- |
Altman Z-Score | 1.92 |
COLL Number of Guru Trades
COLL Volume of Guru Trades
Gurus Latest Trades with NAS:COLL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:COLL is held by these investors
Total 3
Collegium Pharmaceutical Inc Insider Transactions
No Available Data
News about NAS:COLL
Total 0- 1